# A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

> **NCT05894876** · — · TERMINATED · sponsor: **Novo Nordisk A/S** · enrollment: 43 (actual)

## Conditions studied

- Idiopathic Short Stature

## Interventions

- **OTHER:** No treatment is given

## Key facts

- **NCT ID:** NCT05894876
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-04-29
- **Primary completion:** 2025-03-21
- **Final completion:** 2025-03-21
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Due to recruitment challenges, the sponsor has decided to terminate the study prematurely.
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894876, "A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05894876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*